EDESA BIOTECH, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDESA BIOTECH, INC. stock issued during period, value, other for the quarter ending 2024-03-31 was $200.00K.
- EDESA BIOTECH, INC. stock issued during period, value, other for the quarter ending 2023-12-31 was $300.00K.
- EDESA BIOTECH, INC. stock issued during period, value, other for the quarter ending 2023-06-30 was $690.00K.
- EDESA BIOTECH, INC. stock issued during period, value, other for the quarter ending 2021-12-31 was -$58.66K.
- EDESA BIOTECH, INC. stock issued during period, value, other for fiscal 2021 was $41.98K, a 262.81% increase from fiscal 2020.
- EDESA BIOTECH, INC. stock issued during period, value, other for fiscal 2020 was $11.57K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2024-03-31 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-10 | |
| 2023-12-31 | $300.00K 10-Q · filed 2024-02-09 | |
| 2023-06-30 | $690.00K 10-Q · filed 2023-08-09 | |
| 2021-12-31 | -$58.66K 10-Q · filed 2022-02-14 | -$16.68K derived: sum of 4 quarters · filed 2022-02-14 |
| 2021-09-30 | -$4.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $41.98K 10-K · filed 2021-12-28 |
| 2021-06-30 | $15.90K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $26.08K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$60.98K 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $11.57K 10-K · filed 2021-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |